Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term, Open Follow-up of the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine (580299) in Healthy Female Subjects Vaccinated in Study HPV-013

NCT00316706 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00316706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00316706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term, Open Follow-up of the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine (580299) in Healthy Female Subjects Vaccinated in Study HPV-013
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2005
Completion date
January 31, 2009
Enrollment
1,245 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia, papillomavirus infection